Search hospitals > Arizona > Scottsdale
HonorHealth Research Institute
Claim this profileScottsdale, Arizona 85258
Global Leader in Pancreatic Cancer
Global Leader in Solid Tumors
Conducts research for Cancer
Conducts research for Lung Cancer
Conducts research for Colorectal Cancer
152 reported clinical trials
14 medical researchers
Summary
HonorHealth Research Institute is a medical facility located in Scottsdale, Arizona. This center is recognized for care of Pancreatic Cancer, Solid Tumors, Cancer, Lung Cancer, Colorectal Cancer and other specialties. HonorHealth Research Institute is involved with conducting 152 clinical trials across 257 conditions. There are 14 research doctors associated with this hospital, such as Vincent Chung, MD, Michael S Gordon, MD, Sunil Sharma, and Erkut Borazanci, MD.Area of expertise
1Pancreatic Cancer
Global LeaderStage IV
Stage III
metastatic
2Solid Tumors
Global LeaderStage IV
Stage III
metastatic
Top PIs
Vincent Chung, MDCity of Hope Medical Center3 years of reported clinical research
Expert in Pancreatic Cancer
Studies Lung Cancer
21 reported clinical trials
33 drugs studied
Michael S Gordon, MDHonor Health Research Institute3 years of reported clinical research
Studies Solid Tumors
Studies Cancer
18 reported clinical trials
26 drugs studied
Sunil SharmaHonorHealth Research Institute1 year of reported clinical research
Studies Colorectal Cancer
Studies Cancer
16 reported clinical trials
34 drugs studied
Erkut Borazanci, MDHonor Health Research Institute2 years of reported clinical research
Expert in Pancreatic Cancer
Studies Solid Tumors
16 reported clinical trials
27 drugs studied
Clinical Trials running at HonorHealth Research Institute
Pancreatic Cancer
Lung Cancer
Solid Tumors
Colorectal Cancer
Breast Cancer
Melanoma
Non-Small Cell Lung Cancer
Cancer
Ovarian Cancer
Myasthenia Gravis
Ivaltinostat + Capecitabine
for Pancreatic Cancer
This trial tests ivaltinostat with capecitabine in patients with advanced pancreatic cancer who have not worsened after initial treatment. The goal is to find a safe and effective dose and to see if this combination can better control the cancer. Capecitabine is a medication that is converted into another drug in the body, showing better selectivity and tolerability in tumor tissues.
Recruiting3 awards Phase 1 & 211 criteria
LY4170156
for Breast Cancer
The purpose of this study is to find out whether the study drug, LY4170156, is safe, tolerable and effective in participants with advanced solid tumors. The study is conducted in two parts - phase Ia (dose-escalation, dose-optimization) and phase Ib (dose-expansion). The study will last up to approximately 4 years.
Recruiting1 award Phase 11 criteria
RAS(ON) Inhibitors
for Gastrointestinal Cancer
The purpose of this platform study is to evaluate the safety, tolerability, pharmacokinetics (PK), and preliminary antitumor activity of novel RAS(ON) inhibitors combined with Standard(s) of Care (SOC) or with novel agents. The current subprotocols include the following: Subprotocol A: RMC-6236 + 5-fluorouracil-based regimens Subprotocol B: RMC-6236 + cetuximab with or without mFOLFOX6 Subprotocol C: RMC-6236 + gemcitabine + nab-paclitaxel Subprotocol D: RMC-9805 with or without RMC-6236 + 5-fluorouracil-based regimens Subprotocol E: RMC-9805 with or without RMC-6236 + cetuximab with or without mFOLFOX6 Subprotocol F: RMC-9805 with or without RMC-6236 + gemcitabine + nab-paclitaxel
Recruiting1 award Phase 1 & 24 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at HonorHealth Research Institute?
HonorHealth Research Institute is a medical facility located in Scottsdale, Arizona. This center is recognized for care of Pancreatic Cancer, Solid Tumors, Cancer, Lung Cancer, Colorectal Cancer and other specialties. HonorHealth Research Institute is involved with conducting 152 clinical trials across 257 conditions. There are 14 research doctors associated with this hospital, such as Vincent Chung, MD, Michael S Gordon, MD, Sunil Sharma, and Erkut Borazanci, MD.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.